Health Tech, or digital health, helps us understand and take control of our own health. But we also cover more traditional health news like medicines, vaccines and medical procedures.
Up to two decades before people develop the characteristic memory loss and confusion of Alzheimer's disease, damaging clumps of protein start to build up in their brains. Now, a blood test to detect such early brain changes has moved one step closer to clinical use.
The system will give people suffering from epilepsy warning that a seizure is imminent, enabling them to take medication—or alert a friend, relative or medical professional.
Last month UPS announced that it was the first to receive approval from the Federal Aviation Administration (FAA) to operate its full drone airline. It allowed them to expand upon their small drone delivery pilot programs into a nation wide network.
Doctors have placed humans in suspended animation for the first time, as part of a trial in the US that aims to make it possible to fix traumatic injuries that would otherwise cause death.
Ebola vaccine approved in Europe in landmark moment in fight against a deadly disease.
Microsoft and SRL Diagnostics have developed an AI tool that helps detect cervical cancer.
WeWalk [https://wewalk.io/en/], a Turkish startup, has developed a smart cane that has the potential to be truly life-changing for the blind all around the world. As the World Health Organization reports [https://www.who.int/blindness/GLOBALDATAFINALforweb.pdf], there are over 250 million people globally who are
Mediview [https://mediviewxr.com/] is an Ohio based startup whose vision to develop an organization that participates in patient-centered cancer care via disruptive surgical navigation medical technology. Recently, they raised $4.5 million for MediView XR. A technology to equip surgeons with augmented reality imagery that effectively gives them 3D
💉 Tuberculosis kills 1.5 million people around the world each year. This vaccine could revolutionize treatment and provide long-term protection. It has already cleared a critical phase of clinical trials and been tested on more than 3,500 adults in TB endemic regions of South Africa, Kenya and Zambia, researchers